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We read with interest the recent study by Scannapieco and
colleagues [1], which concluded that twice-daily oral rinse
with 0.12% chlorhexidine failed to reduce the number of
potential respiratory pathogens in dental plaque, mortality, the
incidence of ventilator-associated pneumonia (VAP), the
length of intensive care unit (ICU) stay and the duration of
mechanical ventilation in trauma ICU patients.
Trauma ICU patients are similar to mixed ICU patients with
respect to risk factors for developing VAP, unlike patients
undergoing elective cardiac surgery. Use of 0.12% chlor-
hexidine decreases the incidence of VAP in patients under-
going elective cardiac surgery. In mixed ICU patients, chlor-
hexidine at concentrations less than 0.2% has consistently
been shown to have no benefit [2]. A randomized trial using
2% chlorhexidine has, however, demonstrated a reduction in
VAP rates in these patients [3]. A previous study showed that
12-hourly application of chlorhexidine has a sustained
preventive effect on biofilm formation [4]. The lack of benefit
from twice-daily oral cleansing with chlorhexidine in the
present study may be due to the lower concentration of
chlorhexidine.
The authors’ recommendation for investigation into mecha-
nical plaque removal with chlorhexidine would conceptually
have some added benefit. Mechanical plaque removal with
chlorhexidine, however, has not affected outcomes in ICU
patients in two studies [5,6].
We therefore suggest that further studies using oral chlor-
hexidine in ICU patients should be conducted using higher
concentrations (2%) to test the most appropriate frequency
of use, since oral cleansing is a nursing-driven intervention
and clinical trials with chlorhexidine are yet to demonstrate a
mortality benefit.
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ICU = intensive care unit; VAP = ventilator-associated pneumonia.